Heptahydrate

Synopsis

Heptahydrate Mineral Salts: A Comprehensive Reference

Overview and Nomenclature

Heptahydrate is not a single dietary ingredient but a chemical descriptor denoting a compound whose crystalline structure incorporates exactly seven molecules of water of crystallization per formula unit (from the Greek hepta, "seven," and hydor, "water"). The term appears in the names of several nutritionally and medically significant inorganic mineral salts that are marketed and used as dietary supplements, over-the-counter medicines, and pharmaceutical ingredients. The three most prominent heptahydrate salts in the dietary supplement and clinical contexts are:

Magnesium sulfate heptahydrate (MgSO₄·7H₂O), commonly known as Epsom salt
Zinc sulfate heptahydrate (ZnSO₄·7H₂O), historically known as white vitriol or goslarite
Ferrous sulfate heptahydrate (FeSO₄·7H₂O), also known as iron(II) sulfate heptahydrate or green vitriol

Each of these compounds delivers an essential mineral in a hydrated inorganic sulfate form, and each has a distinct history of traditional use, established biochemical role, and body of clinical evidence. This article covers all three in detail, organized by compound.

Part I: Magnesium Sulfate Heptahydrate (Epsom Salt)

Identity and Chemical Characteristics

Magnesium sulfate heptahydrate is a chemical compound, a salt composed of magnesium and sulfate. It is a white crystalline solid, soluble in water. Magnesium sulfate is usually encountered in the form of a hydrate MgSO₄·nH₂O, for various values of n between 1 and 11, and the most common form is the heptahydrate MgSO₄·7H₂O, known as Epsom salt, a household chemical with many traditional uses including bath salts.

The heptahydrate takes its common name "Epsom salt" from a bitter saline spring in Epsom in Surrey, England, where the salt was produced from the springs that arise where the porous chalk of the North Downs meets the impervious London clay. The heptahydrate readily loses one equivalent of water to form the hexahydrate. It is a natural source of both magnesium and sulphur. Epsom salts are commonly used in bath salts, exfoliants, muscle relaxers and pain relievers.

Its CAS number is 10034-99-8 and its molecular weight is 246.47 g/mol. Magnesium sulfate heptahydrate is available in forms meeting the specifications of the European Pharmacopoeia (Ph. Eur.), British Pharmacopoeia (BP), Japanese Pharmacopoeia (JP), United States Pharmacopeia (USP), and Food Chemical Codex (FCC).

In its mineral form, magnesium sulfate heptahydrate is known as epsomite. Almost all known mineralogical forms of MgSO₄ occur as hydrates. Epsomite is the natural analogue of "Epsom salt." The anhydrous form and several hydrates occur in nature as minerals, and the salt is a significant component of the water from some springs.

Traditional and Historical Use

The heptahydrate takes its common name from the springs at Epsom in Surrey, England, where the mineral was first characterised from the naturally occurring spring waters. The most well-known name for magnesium sulfate heptahydrate is Epsom salt, derived from the town of Epsom in Surrey, England, where the mineral was first discovered in the natural spring waters. Other names for this compound include magnesium sulfate crystals, magnesium sulfate hydrate, and bitter salt.

Epsom salt has been traditionally used as a component of bath salts. Traditionally, it is also used to prepare foot baths, intended to soothe sore feet. In addition to its use in foods as a flavor enhancer, nutrient supplement and processing aid, magnesium sulfate (as Epsom salt) is employed in over-the-counter preparations as a laxative.

Magnesium sulfate has been used throughout the 20th century for prevention of eclamptic seizures. Throughout the 20th century, several large clinical trials verified magnesium sulfate as the treatment of choice for eclampsia, establishing the history of its management.

Key Constituents and Mechanism of Action

Magnesium is an abundant mineral in the body, naturally present in many foods, available as a dietary supplement, and present in some medicines. Magnesium is a cofactor in more than 300 enzyme systems that regulate diverse biochemical reactions in the body, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Magnesium is required for energy production, oxidative phosphorylation, and glycolysis. It contributes to the structural development of bone and is required for the synthesis of DNA, RNA, and the antioxidant glutathione.

Magnesium is a cofactor in more than 300 enzyme systems that regulate diverse biochemical reactions in the body, including protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Magnesium is required for energy production, oxidative phosphorylation, and glycolysis.

The adult human body contains approximately 25 g of magnesium, approximately 50–60% of which resides in the bones; most of what remains is present in soft tissues, and less than 1% resides outside of cells.

For every 1 gram of magnesium sulfate, it contains 98.6 mg or 8.12 mEq of elemental magnesium.

In the context of eclampsia, several mechanisms have been described, including the effects of magnesium sulfate on peripheral and cerebral vasodilation, blood-brain barrier protection, and its action as an anticonvulsant. Though the specific mechanisms of action remain unclear, the effect of magnesium sulfate in the prevention of eclampsia is likely multi-factorial.

Regarding deficiency, the most common symptoms of hypomagnesemia are somewhat nonspecific and include muscle weakness, muscle cramps, and increased irritability of the nervous system with tremors or muscle spasms. Symptoms are usually mild or not present when hypomagnesemia is between 0.5 and 0.7 mmol/L but become more apparent and/or severe when serum magnesium falls below 0.5 mmol/L.

Concerning supplement bioavailability, supplements can contain a variety of different forms of magnesium, and the absorption of these forms varies. In general, forms of magnesium that dissolve well in liquid have higher absorption than other forms, and the aspartate, citrate, lactate, and chloride forms of magnesium tend to have higher bioavailability than magnesium oxide and magnesium sulfate.

Scientific Evidence by Area of Use

Laxative Use (Oral)

Magnesium sulfate USP (heptahydrate) is classified officially in the United States as a saline laxative and is indicated for the relief of occasional constipation, generally producing a bowel movement within one half to six hours. Oral magnesium sulfate, or magnesium hydroxide, is commonly used as a saline laxative. The mechanism of action as a saline laxative is osmotic: magnesium ions draw water into the intestinal lumen, stimulating peristalsis. This is a well-established, pharmacopeia-recognized application.

Eclampsia and Preeclampsia

Magnesium sulfate is the ideal drug for the prevention and treatment of eclampsia, and its universal use is recommended by the World Health Organization. For eclamptic seizure prophylaxis in preeclamptic women, MgSO₄ is superior to phenytoin, nimodipine, diazepam, and placebo. In the multinational Collaborative Eclampsia Trial, MgSO₄ reduced the risk of recurrent seizures in eclamptic women by 52% when compared to diazepam and by 67% when compared to phenytoin.

A systematic review and meta-analysis was conducted to condense the evidence on clinical efficacy and safety of 12-hour MgSO₄ compared to 24-hour MgSO₄ in the prophylaxis and treatment of seizures in pre-eclampsia and eclampsia patients. Thirteen RCTs with 2,809 patients were included. The investigators found an overall low risk of bias in nine trials, some concern in two trials, and high risk in another two studies.

Magnesium sulfate is a medication used to manage and treat multiple clinical conditions. Its indications include the treatment of magnesium electrolyte abnormalities, eclampsia, and constipation.

Hypomagnesemia and Magnesium Deficiency

Magnesium is an essential mineral involved in many physiological functions, and magnesium sulfate heptahydrate is often used to treat magnesium deficiency. This condition can lead to symptoms such as muscle cramps, weakness, and irregular heart rhythms. Magnesium sulfate supplements can restore magnesium levels in the body, particularly in cases of severe deficiency.

Topical/Bath Use — Evidence Assessment

Magnesium sulfate heptahydrate is frequently used in Epsom salt baths for its muscle-relaxing properties. When dissolved in warm water, it is claimed to be absorbed through the skin, providing relief from sore muscles and joint pain. This application is especially popular for athletes or individuals suffering from chronic muscle tension or inflammation. However, the scientific evidence for transdermal magnesium absorption from bath soaks is considered limited and preliminary. Robust, controlled clinical trials demonstrating significant systemic magnesium increases from topical Epsom salt application are not well established in the published peer-reviewed literature, and this remains an area requiring further investigation.

Dosage Forms and Reported Dosages

Magnesium sulfate administration can be oral (PO), intramuscular (IM), intraosseous (IO), or intravenous (IV). For every 1 gram of magnesium sulfate, it contains 98.6 mg of elemental magnesium. Magnesium sulfate can be combined with dextrose 5% in water to make intravenous solutions. Orally, magnesium sulfate is available as a capsule or powder (Epsom salt), which can be combined with water to form an oral solution.

In the context of preeclampsia clinical trials, serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour have been studied as maintenance doses to prevent eclampsia in women with severe preeclampsia.

Safety Considerations and Drug Interactions

When giving magnesium sulfate, there are minimal side effects with standard therapeutic doses. Patients most commonly complain of minor facial flushing and warmth with the administration; however, symptoms typically resolve spontaneously.

In patients with neuromuscular disease, such as in myasthenia gravis, the neuromuscular function may worsen at lower concentrations of medication. If given rapidly or in high doses, patients may experience transient hypotension due to smooth muscle involvement.

Magnesium-rich supplements or medications can decrease the absorption of oral bisphosphonates, such as alendronate (Fosamax®), used to treat osteoporosis. Use of magnesium-rich supplements or medications and oral bisphosphonates should be separated by at least 2 hours.

Magnesium can form insoluble complexes with tetracyclines, such as demeclocycline and doxycycline, as well as quinolone antibiotics, such as ciprofloxacin and levofloxacin. These antibiotics should be taken at least 2 hours before or 4–6 hours after a magnesium-containing supplement.

Prescription proton pump inhibitor (PPI) drugs, such as esomeprazole magnesium and lansoprazole, when taken for prolonged periods — typically more than a year — can cause hypomagnesemia.

Hot or warm soaks should not be used by individuals with diabetes except on the advice of a physician.

Part II: Zinc Sulfate Heptahydrate

Identity and Chemical Characteristics

Zinc sulfate is an inorganic compound with the chemical formula ZnSO₄, existing primarily in hydrated forms such as the colorless or white crystalline heptahydrate ZnSO₄·7H₂O and monohydrate ZnSO₄·H₂O, which are highly soluble in water (approximately 57.7 g/100 mL at 25°C). It serves as a key source of the essential micronutrient zinc, with applications spanning agriculture, medicine, and industry.

The heptahydrate is isostructural with ferrous sulfate heptahydrate. The solid consists of [Zn(H₂O)₆]²⁺ ions interacting with sulfate and one water of crystallization by hydrogen bonds. As a mineral, ZnSO₄·7H₂O is known as goslarite. It is an inorganic chemical and can be found in the form of the mineral goslarite. It is also known as white vitriol, and is usually solid and can be found in the shape of white crystals or powder.

Zinc sulfate is the inorganic compound with the formula ZnSO₄ and historically known as "white vitriol." It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.

Traditional and Historical Use

The medical use of zinc sulfate began as early as the 1600s. Centuries before zinc was recognized as a distinct element, zinc ores were used for making brass (a mixture of copper and zinc). A brass dating from between 1400–1000 BC has been found in Palestine. An alloy containing 87% zinc was found in prehistoric ruins in Transylvania. The smelting of zinc ores with copper was apparently discovered in Cyprus and was used later by the Romans. Metallic zinc was produced in the 13th century in India by reducing calamine (zinc carbonate, ZnCO₃) with organic substances such as wool.

Zinc sulfate heptahydrate has historically been used in medicine as an astringent and emetic. During the 1918 flu pandemic in New Zealand, inhalation chambers were set up in towns and cities as a means to boost immunity. Zinc sulfate has also traditionally been used as a preservative for wood and skins, as a mordant in dyeing, and in the preparation of various zinc-containing medicines.

Key Constituents and Mechanisms of Action

Zinc has been identified as a cofactor for over 70 different enzymes, including alkaline phosphatase, lactic dehydrogenase, and both RNA and DNA polymerase. Zinc facilitates wound healing, helps maintain normal growth rates, normal skin hydration, and the senses of taste and smell.

Approximately 20 to 30% of dietary zinc is absorbed, primarily from the duodenum and ileum. The amount absorbed is dependent on the bioavailability from food. Zinc is most bioavailable from red meat and oysters. Phytates may impair absorption by chelation and formation of insoluble complexes at an alkaline pH.

Zinc is an essential mineral that plays a crucial role in many bodily functions, including immune system support and wound healing.

Scientific Evidence by Area of Use

Zinc Deficiency

Zinc sulfate heptahydrate is a hydrate that is the heptahydrate form of zinc sulfate. It is a dietary supplement used for zinc deficiency and to prevent the condition in those at high risk. In the United States, zinc sulfate is available as a generic medication. In the United Kingdom, it is available over the counter.

Diarrhea in Children

Clinical trials have shown that zinc supplementation helps shorten the duration of diarrhea in children who live in low-income countries. A 2016 Cochrane Review included 33 trials that compared the effects of zinc supplementation with placebo in 10,841 children aged 1 month to 5 years with acute or persistent diarrhea. Most studies were conducted in Asian countries with high rates of zinc deficiency. The investigators administered zinc in the form of zinc acetate, zinc gluconate, or zinc sulfate. The most common dose was 20 mg/day, and about half the studies administered zinc for 2 weeks.

The authors concluded, on the basis of evidence of low to moderate certainty, that zinc supplementation shortens the duration of diarrhea by about half a day in children older than 6 months and reduces the likelihood that diarrhea will persist for at least 7 days by 27%. In children younger than 6 months, however, zinc supplementation did not affect the mean duration of diarrhea or the proportion of children affected.

The use of zinc sulfate supplements together with oral rehydration therapy decreases the number of bowel movements and the time until the diarrhea stops. Its use in this situation is recommended by the World Health Organization.

Respiratory Infections and Pneumonia

Potential benefits being studied in clinical trials include reduced duration and severity of diarrhea, faster recovery from pneumonia, improved appetite and growth in malnourished children, and better outcomes in treating serious bacterial infections in infants.

Wilson's Disease

There is some evidence that zinc is effective in reducing hepatic and neurological symptoms of Wilson's disease. This is considered a clinically recognized but not universally first-line use of zinc supplementation.

Type 2 Diabetes Prevention

Studies have administered 30 mg/day to 100 mg/day zinc (in the form of zinc sulfate or zinc amino chelate) for 4 to 12 weeks, but the quality of studies could not be assessed because of the lack of relevant information in the study reports. The Cochrane Review authors concluded that evidence is lacking on which to base conclusions about the use of zinc supplementation to prevent type 2 diabetes. However, studies published since the Cochrane Review have had more positive findings.

Inflammatory Conditions

Zinc is a dietary supplement with compelling preclinical evidence for potential health benefit that could be expanded not only to the HIV population, but also to other inflammatory conditions that share many facets of HIV infection, namely the persistent intestinal barrier dysfunction, monocyte activation and heightened inflammation state. Such diseases include inflammatory bowel diseases, rheumatoid arthritis, diabetes and even obesity in the general population. This remains an area of active clinical investigation with no definitive trial conclusions yet established.

Parenteral Nutrition

Zinc sulfate is also an important part of parenteral nutrition. Zinc sulfate is a common zinc supplement in parenteral nutrition.

Dosage Forms and Reported Dosages

Zinc sulfate heptahydrate is typically administered orally, either as tablets, suspension, or syrup. The dosage varies depending on the study and the age of the participants, but common doses in clinical trials range from 10 to 20 mg of elemental zinc per day.

In the Cochrane Review on diarrhea, the most common dose used in studies was 20 mg/day of elemental zinc, with about half the studies administering zinc for 2 weeks. For diabetes-related studies, doses of 30 mg/day to 100 mg/day zinc (in the form of zinc sulfate) were administered for 4 to 12 weeks.

Safety Considerations and Drug Interactions

While zinc is generally considered safe, some studies monitor for potential side effects such as vomiting or changes in electrolyte balance. The trials also assess the impact on other micronutrients like copper and iron to ensure safety.

In low concentrations, zinc sulfate heptahydrate is not harmful to human life. If consumed in high concentrations, it can cause harm to human and animal health and even endanger the environment. In high concentrations, it can cause severe damage to various body organs, but this requires repeated or prolonged exposure in the oral form.

Zinc sulfate is a dietary supplement ingredient in use before October 15, 1994, qualifying as a mineral and trace element under the Dietary Supplement Health and Education Act of 1994.

Part III: Ferrous Sulfate Heptahydrate

Identity and Chemical Characteristics

Ferrous sulfate heptahydrate (FeSO₄·7H₂O) plays a critical role in industries including pharmaceuticals, water treatment, and animal nutrition. In its heptahydrate form, it appears as blue-green crystals or granules, odorless, with an astringent taste. In moist air, it oxidizes readily to form basic ferric sulfate. It is soluble in water and insoluble in ethanol.

The heptahydrate of zinc sulfate is isostructural with ferrous sulfate heptahydrate, sharing a similar crystal lattice arrangement. Ferrous sulfate heptahydrate is also historically known as "green vitriol" or "copperas," and its naturally occurring mineral form is melanterite.

Traditional and Historical Use

Iron compounds have been recognized as important nutritional and medicinal substances for centuries. Green vitriol (ferrous sulfate) was known in antiquity, and by the medieval period it was used by physicians in Europe and the Islamic world as a tonic for weakness and pallor — conditions we now recognize as symptoms of iron-deficiency anemia. The mineral ferrous sulfate heptahydrate occurs naturally as melanterite and was historically harvested from mine drainage waters and pyrite-bearing rocks. Its use as a dietary supplement and clinical iron supplement represents a direct extension of these early medicinal applications.

Key Constituents and Mechanisms of Action

A large amount of iron in the body is used for hemoglobin synthesis and iron is critical for many biological functions such as cell proliferation, energy production, DNA synthesis and respiration.

Key functions in animal and human nutrition include hemoglobin synthesis: iron is a fundamental component of hemoglobin, essential for oxygen transport in the blood. A deficiency can result in hypochromic, microcytic anemia.

Iron deficiency and iron-deficiency anemia are a worldwide concern. With 750 million children affected around the world, IDA is the most common nutritional disorder occurring during childhood. Iron deficiency and IDA impair the cognitive development and physical growth of infants and children, depress immune function, and increase morbidity from infectious disease.

Ferrous sulfate heptahydrate is used as a nutritional supplement (iron fortifier) and fruit and vegetable colorant.

Scientific Evidence by Area of Use

Iron-Deficiency Anemia in Children

In a clinical study, children aged 6–53 months presenting with mild or moderate iron-deficiency anemia (blood hemoglobin ranging from 7.0 to 10.9 g/dL and serum ferritin less than 12 ng/mL) were eligible for inclusion. The ferrous sulfate heptahydrate solution at 2 mg/kg/day was administered orally for 3 months. If normalization of either hemoglobin or ferritin was not achieved at month 3, the treatment was continued for another 3 months.

Of the 100 children screened, 21 aged 6–17 months were included and received the study treatment, and 19 were analyzed for hematologic outcomes at month 3. Only one patient continued treatment for the additional 3 months. At month 3, mean hemoglobin and ferritin levels were 12.0 ± 0.7 g/dL and 31.5 ± 19.4 ng/mL, respectively. Hemoglobin and ferritin levels were normalized in 95% (18/19) and 84% (16/19) of the patients, respectively.

Overall, 33.3% of patients experienced at least one adverse event. Only one patient (4.8%) experienced a drug-related adverse event of upper abdominal pain.

A 2 mg/kg daily dose of the oral ferrous sulfate heptahydrate solution provides substantial therapeutic benefit with high levels of tolerability in young children who have mild or moderate iron-deficiency anemia.

Iron-Deficiency Anemia in Adults — Dosing Frequency

A prospective observational study evaluated the efficacy of oral ferrous sulfate treatment with different doses and schedules, its relationship with hepcidin, treatment compliance and gastrointestinal side effects in premenopausal women diagnosed with iron-deficiency anemia. The study included premenopausal female patients aged 18 to 50 years. Patients were divided into 3 groups: twice daily in the first group, once daily in the second group, and once every other day in the third group, with treatment completed over 3 months. Changes in hemoglobin and hepcidin were evaluated before treatment and at two weeks, and changes in ferritin, transferrin saturation, total iron binding capacity, and hemoglobin were evaluated at 3 months.

Significant hemoglobin increase was observed at the end of the second week in the twice-daily and once-daily groups. Previous studies in non-anemic, iron-deficient young women have shown that oral ferrous sulfate therapy given every other day instead of every day, in single doses instead of divided doses, and in low doses improves the efficacy and tolerability of treatment.

Comparison with Iron Polysaccharide Complex

Iron-deficiency anemia affects millions of persons worldwide and is associated with impaired neurodevelopment in infants and children. Ferrous sulfate is the most commonly prescribed oral iron despite iron polysaccharide complex possibly being better tolerated. In a randomized clinical trial, median serum ferritin level increased from 3.0 to 15.6 ng/mL with ferrous sulfate versus 2.0 to 7.5 ng/mL with iron polysaccharide complex over 12 weeks, a greater difference of 10.2 ng/mL (95% CI, 6.2 to 14.1 ng/mL; P < .001) favoring ferrous sulfate.

Dosage Forms and Reported Dosages

In documented clinical studies of pediatric iron-deficiency anemia, the ferrous sulfate heptahydrate solution was administered orally at 2 mg/kg/day for 3 months. In adult women with IDA, oral ferrous sulfate treatment schedules studied include twice-daily dosing, once-daily dosing, and once every other day dosing over 3 months. In other mineral supplementation studies using iron-containing forms, doses are typically individualized based on the severity of deficiency and the patient's weight.

Safety Considerations

While generally safe in regulated amounts, excessive ingestion of ferrous sulfate heptahydrate can lead to iron poisoning, and inhalation of dust may irritate the respiratory tract. Skin and eye contact can cause mild irritation.

Gastrointestinal side effects are among the most commonly reported with oral ferrous sulfate supplementation. In a clinical study of young children, overall 33.3% of patients experienced at least one adverse event, though only 4.8% experienced a drug-related adverse event (upper abdominal pain).

Body Systems Associated with Heptahydrate Mineral Salts

Musculoskeletal system: Magnesium sulfate heptahydrate is associated with muscle relaxation, management of muscle cramps, and bone structural integrity via magnesium's role in bone development.
Neurological system: Magnesium is a cofactor for enzyme systems regulating nerve function. Magnesium sulfate is used clinically for prevention of eclamptic seizures.
Cardiovascular system: Magnesium acts as a calcium channel antagonist, stimulates the production of vasodilator prostacyclins and nitric oxide, and alters vascular responses to vasoactive agonists.
Immune system: Zinc plays a crucial role in immune system support, wound healing, and proper growth and development.
Hematological system: Iron, delivered as ferrous sulfate heptahydrate, is a fundamental component of hemoglobin, essential for oxygen transport in the blood.
Gastrointestinal system: Magnesium sulfate heptahydrate is a recognized saline laxative; zinc sulfate heptahydrate has WHO-endorsed use alongside oral rehydration therapy for diarrhea.
Reproductive/Obstetric system: Magnesium sulfate is considered first-line therapy against eclampsia, and magnesium deficiency in pregnancy has been associated with unfavourable perinatal outcomes.
Metabolic/Endocrine system: Magnesium is a cofactor in enzyme systems that regulate blood glucose control and blood pressure.

Comparative Overview: Forms and Supplemental Context

All three major dietary supplement heptahydrate salts share the property of being highly water-soluble crystalline inorganic compounds whose bioavailable mineral content — magnesium, zinc, or iron — is the pharmacologically active moiety. The heptahydrate form specifically refers to the crystal structure with seven waters of crystallization, which confers greater solubility and typically higher bioavailability in aqueous preparations compared to anhydrous or less-hydrated alternatives. However, as noted by the NIH Office of Dietary Supplements, forms of magnesium that dissolve well in liquid generally have higher absorption, and the aspartate, citrate, lactate, and chloride forms tend to have higher bioavailability than magnesium oxide and magnesium sulfate. This means that for oral magnesium supplementation specifically, the heptahydrate sulfate form may not be the optimal dietary choice despite its traditional use.

For zinc supplementation, zinc sulfate remains one of the most extensively studied forms across clinical trials. For iron supplementation, ferrous sulfate is the most commonly prescribed oral iron across all formulations, and the heptahydrate form is one of its primary pharmaceutical expressions.

Heptahydrate Mineral Salts: A Comprehensive Reference

Overview and Nomenclature

Part I: Magnesium Sulfate Heptahydrate (Epsom Salt)

Identity and Chemical Characteristics

Traditional and Historical Use

Key Constituents and Mechanism of Action

Scientific Evidence by Area of Use

Laxative Use (Oral)

Eclampsia and Preeclampsia

Hypomagnesemia and Magnesium Deficiency

Topical/Bath Use — Evidence Assessment

Dosage Forms and Reported Dosages

Safety Considerations and Drug Interactions

Part II: Zinc Sulfate Heptahydrate

Identity and Chemical Characteristics

Traditional and Historical Use

Key Constituents and Mechanisms of Action

Scientific Evidence by Area of Use

Zinc Deficiency

Diarrhea in Children

Respiratory Infections and Pneumonia

Wilson's Disease

Type 2 Diabetes Prevention

Inflammatory Conditions

Parenteral Nutrition

Dosage Forms and Reported Dosages

Safety Considerations and Drug Interactions

Part III: Ferrous Sulfate Heptahydrate

Identity and Chemical Characteristics

Traditional and Historical Use

Key Constituents and Mechanisms of Action

Scientific Evidence by Area of Use

Iron-Deficiency Anemia in Children

Iron-Deficiency Anemia in Adults — Dosing Frequency

Comparison with Iron Polysaccharide Complex

Dosage Forms and Reported Dosages

Safety Considerations

Body Systems Associated with Heptahydrate Mineral Salts

Comparative Overview: Forms and Supplemental Context

References

Stay informed. Stay healthy.